Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Layered Hybrid Zincophosphites for Room Temperature Phosphorescent Emission.

Mu Y, Ni AY, Han SD, Pan J, Li JH, Wang GM.

Inorg Chem. 2018 Nov 12. doi: 10.1021/acs.inorgchem.8b02792. [Epub ahead of print]

PMID:
30417646
2.

F-18 FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma.

Ito K, Teng R, Schöder H, Humm JL, Ni A, Michaud L, Nakajima R, Yamashita R, Wolchok JD, Weber WA.

J Nucl Med. 2018 Nov 9. pii: jnumed.118.213652. doi: 10.2967/jnumed.118.213652. [Epub ahead of print]

PMID:
30413661
3.

Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.

Soumerai JD, Ni A, Xing G, Huang J, Furman RR, Jones J, Sharman JP, Hallek M, Adewoye AH, Dubowy R, Dreiling L, Zelenetz AD.

Leuk Lymphoma. 2018 Nov 8:1-9. doi: 10.1080/10428194.2018.1540782. [Epub ahead of print]

PMID:
30407886
4.

Electrical Microstimulation of Visual Cerebral Cortex Elevates Psychophysical Detection Thresholds.

Cone JJ, Ni AM, Ghose K, Maunsell JHR.

eNeuro. 2018 Oct 30;5(5). pii: ENEURO.0311-18.2018. doi: 10.1523/ENEURO.0311-18.2018. eCollection 2018 Sep-Oct.

5.

A retrospective seroepidemiologic survey of Chlamydia pneumoniae infection in patients in Beijing between 2008 and 2017.

Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, Ni A.

PLoS One. 2018 Nov 7;13(11):e0206995. doi: 10.1371/journal.pone.0206995. eCollection 2018.

6.

Landscape of PD-1/PD-L1 Regulation and Targeted Immunotherapy.

Ni JM, Ni AP.

Chin Med Sci J. 2018 Sep 20;33(3):174-182. doi: 10.24920/21804.

PMID:
30266108
7.

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.

Dunn LA, Sherman EJ, Baxi SS, Tchekmedyian V, Grewal RK, Larson SM, Pentlow KS, Haque S, Tuttle RM, Sabra MM, Fish S, Boucai L, Walters J, Ghossein RA, Seshan VE, Ni A, Li D, Knauf JA, Pfister DG, Fagin JA, Ho AL.

J Clin Endocrinol Metab. 2018 Sep 25. doi: 10.1210/jc.2018-01478. [Epub ahead of print]

PMID:
30256977
8.

Identification and differential expression of microRNAs in the testis of chicken with high and low sperm motility.

Liu Y, Sun Y, Li Y, Bai H, Xu S, Xu H, Ni A, Yang N, Chen J.

Theriogenology. 2018 Dec;122:94-101. doi: 10.1016/j.theriogenology.2018.09.010. Epub 2018 Sep 13.

PMID:
30243140
9.

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.

Sabari JK, Leonardi GC, Shu CA, Umeton R, Montecalvo J, Ni A, Chen R, Dienstag J, Mrad C, Bergagnini I, Lai WV, Offin M, Arbour KC, Plodkowski AJ, Halpenny DF, Paik PK, Li BT, Riely GJ, Kris MG, Rudin CM, Sholl LM, Nishino M, Hellmann MD, Rekhtman N, Awad MM, Drilon A.

Ann Oncol. 2018 Oct 1;29(10):2085-2091. doi: 10.1093/annonc/mdy334.

PMID:
30165371
10.

The associations between anthropometric measurements and left ventricular structure and function: the Echo-SOL Study.

Ponce S, Allison MA, Swett K, Cai J, Desai AA, Hurwitz BE, Ni A, Schneiderman N, Shah SJ, Spevack DM, Talavera GA, Rodriguez CJ.

Obes Sci Pract. 2018 Jun 14;4(4):387-395. doi: 10.1002/osp4.279. eCollection 2018 Aug.

11.

Tuning Parameter Selection in Cox Proportional Hazards Model with a Diverging Number of Parameters.

Ni A, Cai J.

Scand Stat Theory Appl. 2018 Sep;45(3):557-570. doi: 10.1111/sjos.12313. Epub 2018 Jan 16.

PMID:
30147217
12.

Inhibition of Noncanonical Murine Double Minute 2 Homolog Abrogates Ocular Inflammation through NF-κB Suppression.

Fan Y, Zhang W, Ni A, Mahato B, Chavala SH.

Am J Pathol. 2018 Sep;188(9):2087-2096. doi: 10.1016/j.ajpath.2018.05.017. Epub 2018 Jul 3.

PMID:
30126549
13.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, Sabari JK, Caramella C, Plodkowski AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD.

J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.

PMID:
30125216
14.

Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers.

Offin M, Rizvi H, Tenet M, Ni A, Sanchez-Vega F, Li BT, Drilon A, Kris MG, Rudin CM, Schultz N, Arcila ME, Ladanyi M, Riely GJ, Yu H, Hellmann MD.

Clin Cancer Res. 2018 Jul 25. doi: 10.1158/1078-0432.CCR-18-1102. [Epub ahead of print]

PMID:
30045933
15.

Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.

Drilon A, Lin JJ, Filleron T, Ni A, Milia J, Bergagnini I, Hatzoglou V, Velcheti V, Offin M, Li B, Carbone DP, Besse B, Mok T, Awad MM, Wolf J, Owen D, Camidge DR, Riely GJ, Peled N, Kris MG, Mazieres J, Gainor JF, Gautschi O.

J Thorac Oncol. 2018 Oct;13(10):1595-1601. doi: 10.1016/j.jtho.2018.07.004. Epub 2018 Jul 11.

PMID:
30017832
16.

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Santini FC, Rizvi H, Plodkowski AJ, Ni A, Lacouture ME, Gambarin-Gelwan M, Wilkins O, Panora E, Halpenny DF, Long NM, Kris MG, Rudin CM, Chaft JE, Hellmann MD.

Cancer Immunol Res. 2018 Sep;6(9):1093-1099. doi: 10.1158/2326-6066.CIR-17-0755. Epub 2018 Jul 10.

PMID:
29991499
17.

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

Li BT, Shen R, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, Brzostowski EB, Riely GJ, Solit DB, Hyman DM, Drilon A, Rudin CM, Berger MF, Baselga J, Scaltriti M, Arcila ME, Kris MG.

J Clin Oncol. 2018 Aug 20;36(24):2532-2537. doi: 10.1200/JCO.2018.77.9777. Epub 2018 Jul 10.

PMID:
29989854
18.

Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.

Vardhana S, Hamlin PA, Yang J, Zelenetz A, Sauter CS, Matasar MJ, Ni A, Yahalom J, Moskowitz CH.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2133-2138. doi: 10.1016/j.bbmt.2018.06.009. Epub 2018 Jun 15.

PMID:
29909154
19.

Toward a panoramic perspective of the association between environmental factors and cardiovascular disease: An environment-wide association study from National Health and Nutrition Examination Survey 1999-2014.

Zhuang X, Guo Y, Ni A, Yang D, Liao L, Zhang S, Zhou H, Sun X, Wang L, Wang X, Liao X.

Environ Int. 2018 Sep;118:146-153. doi: 10.1016/j.envint.2018.05.046. Epub 2018 Jun 4.

PMID:
29879615
20.

Cognition as a Window into Neuronal Population Space.

Ruff DA, Ni AM, Cohen MR.

Annu Rev Neurosci. 2018 Jul 8;41:77-97. doi: 10.1146/annurev-neuro-080317-061936.

PMID:
29799773
21.

The neural signatures of egocentric bias in normative decision-making.

Feng C, Feng X, Wang L, Wang L, Gu R, Ni A, Deshpande G, Li Z, Luo YJ.

Brain Imaging Behav. 2018 May 16. doi: 10.1007/s11682-018-9893-1. [Epub ahead of print]

PMID:
29767303
22.

Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers.

Ni A, Lee Cantrell F, Clark RF.

Am J Emerg Med. 2018 Aug;36(8):1459-1462. doi: 10.1016/j.ajem.2018.04.066. Epub 2018 May 3.

PMID:
29754964
23.

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LMB, Abu-Akeel M, Liu C, Sauter JL, Rekhtman N, Chang E, Callahan MK, Chaft JE, Voss MH, Tenet M, Li XM, Covello K, Renninger A, Vitazka P, Geese WJ, Borghaei H, Rudin CM, Antonia SJ, Swanton C, Hammerbacher J, Merghoub T, McGranahan N, Snyder A, Wolchok JD.

Cancer Cell. 2018 May 14;33(5):843-852.e4. doi: 10.1016/j.ccell.2018.03.018. Epub 2018 Apr 12.

24.

Genome-wide detection of CNVs associated with beak deformity in chickens using high-density 600K SNP arrays.

Bai H, Sun Y, Liu N, Liu Y, Xue F, Li Y, Xu S, Ni A, Ye J, Chen Y, Chen J.

Anim Genet. 2018 Jun;49(3):226-236. doi: 10.1111/age.12652. Epub 2018 Apr 11.

PMID:
29642269
25.

An organic-inorganic hybrid zinc phosphite framework with room temperature phosphorescence.

Ni AY, Mu Y, Pan J, Han SD, Shang MM, Wang GM.

Chem Commun (Camb). 2018 Apr 10;54(30):3712-3714. doi: 10.1039/c8cc00724a.

PMID:
29578228
26.

Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance.

Yu HA, Suzawa K, Jordan E, Zehir A, Ni A, Kim R, Kris MG, Hellmann MD, Li BT, Somwar R, Solit DB, Berger MF, Arcila M, Riely GJ, Ladanyi M.

Clin Cancer Res. 2018 Jul 1;24(13):3108-3118. doi: 10.1158/1078-0432.CCR-17-2961. Epub 2018 Mar 12.

PMID:
29530932
27.

The second conserved motif in bacterial laccase regulates catalysis and robustness.

Jin L, Yang X, Sheng Y, Cao H, Ni A, Zhang Y.

Appl Microbiol Biotechnol. 2018 May;102(9):4039-4048. doi: 10.1007/s00253-018-8863-2. Epub 2018 Mar 7.

PMID:
29516145
28.

Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.

Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A.

PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018.

29.

Learning and attention reveal a general relationship between population activity and behavior.

Ni AM, Ruff DA, Alberts JJ, Symmonds J, Cohen MR.

Science. 2018 Jan 26;359(6374):463-465. doi: 10.1126/science.aao0284.

PMID:
29371470
30.

Environment-wide association study to identify novel factors associated with peripheral arterial disease: Evidence from the National Health and Nutrition Examination Survey (1999-2004).

Zhuang X, Ni A, Liao L, Guo Y, Dai W, Jiang Y, Zhou H, Hu X, Du Z, Wang X, Liao X.

Atherosclerosis. 2018 Feb;269:172-177. doi: 10.1016/j.atherosclerosis.2018.01.006. Epub 2018 Jan 12.

PMID:
29366990
31.

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

Rizvi H, Sanchez-Vega F, La K, Chatila W, Jonsson P, Halpenny D, Plodkowski A, Long N, Sauter JL, Rekhtman N, Hollmann T, Schalper KA, Gainor JF, Shen R, Ni A, Arbour KC, Merghoub T, Wolchok J, Snyder A, Chaft JE, Kris MG, Rudin CM, Socci ND, Berger MF, Taylor BS, Zehir A, Solit DB, Arcila ME, Ladanyi M, Riely GJ, Schultz N, Hellmann MD.

J Clin Oncol. 2018 Mar 1;36(7):633-641. doi: 10.1200/JCO.2017.75.3384. Epub 2018 Jan 16.

32.

The Effects of a Macromolecular Charring Agent with Gas Phase and Condense Phase Synergistic Flame Retardant Capability on the Properties of PP/IFR Composites.

Chen H, Wang J, Ni A, Ding A, Han X, Sun Z.

Materials (Basel). 2018 Jan 11;11(1). pii: E111. doi: 10.3390/ma11010111.

33.

Alteration of glucocorticoid receptors and exacerbation of inflammation during lytic cytomegalovirus infection in THP-1 cells.

Wang S, Dou Y, Yang H, Ni A, Zhang R, Qian J.

FEBS Open Bio. 2017 Oct 30;7(12):1924-1931. doi: 10.1002/2211-5463.12334. eCollection 2017 Dec.

34.

Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer.

Arbour KC, Jordan E, Kim HR, Dienstag J, Yu HA, Sanchez-Vega F, Lito P, Berger M, Solit DB, Hellmann M, Kris MG, Rudin CM, Ni A, Arcila M, Ladanyi M, Riely GJ.

Clin Cancer Res. 2018 Jan 15;24(2):334-340. doi: 10.1158/1078-0432.CCR-17-1841. Epub 2017 Oct 31.

PMID:
29089357
35.

Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3.

Sun XY, Qu Y, Ni AR, Wang GX, Huang WB, Chen ZP, Lv ZF, Zhang S, Lindsay H, Zhao S, Li XN, Feng BH.

Oncotarget. 2017 Sep 8;8(43):75232-75242. doi: 10.18632/oncotarget.20744. eCollection 2017 Sep 26.

36.

Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.

Arbour KC, Kris MG, Riely GJ, Ni A, Beal K, Daras M, Hayes SA, Young RJ, Rodriguez CR, Ahn L, Pao W, Yu HA.

Cancer. 2018 Jan 1;124(1):105-109. doi: 10.1002/cncr.30990. Epub 2017 Sep 21.

PMID:
28940498
37.

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH.

Blood. 2017 Nov 16;130(20):2196-2203. doi: 10.1182/blood-2017-06-788877. Epub 2017 Sep 5.

38.

Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.

Arbour KC, Naidoo J, Steele KE, Ni A, Moreira AL, Rekhtman N, Robbins PB, Karakunnel J, Rimner A, Huang J, Riely GJ, Hellmann MD.

PLoS One. 2017 Aug 3;12(8):e0182665. doi: 10.1371/journal.pone.0182665. eCollection 2017.

39.

A regularized variable selection procedure in additive hazards model with stratified case-cohort design.

Ni A, Cai J.

Lifetime Data Anal. 2018 Jul;24(3):443-463. doi: 10.1007/s10985-017-9402-7. Epub 2017 Jul 28.

PMID:
28755021
40.

Spatially tuned normalization explains attention modulation variance within neurons.

Ni AM, Maunsell JHR.

J Neurophysiol. 2017 Sep 1;118(3):1903-1913. doi: 10.1152/jn.00218.2017. Epub 2017 Jul 12.

41.

Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.

Schilsky JB, Ni A, Ahn L, Datta S, Travis WD, Kris MG, Chaft JE, Rekhtman N, Hellmann MD.

Lung Cancer. 2017 Jun;108:205-211. doi: 10.1016/j.lungcan.2017.03.015. Epub 2017 Mar 28.

PMID:
28625636
42.

Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos).

LaVange L, Davis SM, Hankinson J, Enright P, Wilson R, Barr RG, Aldrich TK, Kalhan R, Lemus H, Ni A, Smith LJ, Talavera GA.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):993-1003. doi: 10.1164/rccm.201610-1987OC.

43.

Variable selection for case-cohort studies with failure time outcome.

Ni AI, Cai J, Zeng D.

Biometrika. 2016 Sep;103(3):547-562. doi: 10.1093/biomet/asw027. Epub 2016 Aug 10.

44.

Association of Visual Acuity with Ocular Dominance in 2045 Myopic Patients.

Zhou D, Ni N, Ni A, Chen Q, Hu DN, Zhou J.

Curr Eye Res. 2017 Aug;42(8):1155-1159. doi: 10.1080/02713683.2017.1297464. Epub 2017 May 11.

PMID:
28494159
45.

Expression of the inhibitory receptor NKG2A correlates with increased liver and splenic NK cell response to activating receptor engagement.

Meyer CE, Key PN, Zhu T, Shabsovich M, Ni A, Tripathy SK.

Immun Inflamm Dis. 2017 Jun;5(2):177-189. doi: 10.1002/iid3.156. Epub 2017 Mar 24.

46.

The time course of morphological processing during spoken word recognition in Chinese.

Shen W, Qu Q, Ni A, Zhou J, Li X.

Psychon Bull Rev. 2017 Dec;24(6):1957-1963. doi: 10.3758/s13423-017-1274-z.

PMID:
28361435
47.

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

Jordan EJ, Kim HR, Arcila ME, Barron D, Chakravarty D, Gao J, Chang MT, Ni A, Kundra R, Jonsson P, Jayakumaran G, Gao SP, Johnsen HC, Hanrahan AJ, Zehir A, Rekhtman N, Ginsberg MS, Li BT, Yu HA, Paik PK, Drilon A, Hellmann MD, Reales DN, Benayed R, Rusch VW, Kris MG, Chaft JE, Baselga J, Taylor BS, Schultz N, Rudin CM, Hyman DM, Berger MF, Solit DB, Ladanyi M, Riely GJ.

Cancer Discov. 2017 Jun;7(6):596-609. doi: 10.1158/2159-8290.CD-16-1337. Epub 2017 Mar 23.

48.

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

Gardner EE, Lok BH, Schneeberger VE, Desmeules P, Miles LA, Arnold PK, Ni A, Khodos I, de Stanchina E, Nguyen T, Sage J, Campbell JE, Ribich S, Rekhtman N, Dowlati A, Massion PP, Rudin CM, Poirier JT.

Cancer Cell. 2017 Feb 13;31(2):286-299. doi: 10.1016/j.ccell.2017.01.006.

49.

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.

Osorio JC, Ni A, Chaft JE, Pollina R, Kasler MK, Stephens D, Rodriguez C, Cambridge L, Rizvi H, Wolchok JD, Merghoub T, Rudin CM, Fish S, Hellmann MD.

Ann Oncol. 2017 Mar 1;28(3):583-589. doi: 10.1093/annonc/mdw640.

50.

Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy.

Chen J, Gao P, Yuan S, Li R, Ni A, Chu L, Ding L, Sun Y, Liu XY, Duan Y.

ACS Nano. 2016 Dec 27;10(12):11548-11560. doi: 10.1021/acsnano.6b06182. Epub 2016 Dec 15.

PMID:
27977128

Supplemental Content

Support Center